A bare metal stent (BMS) for use in the superficial femoral artery (SFA) yields comparable safety and efficacy to drug-eluting stents at 12 months, according to data from a multinational trial ...
Caroline Lai was drawn to the 200-year-old building where Inn 422 in Lebanon County had operated for nearly a quarter century. Earlier this year the owner of several area Asian establishments and Bijo ...
Terumo has planned to release Misago RX in the U.S. Misago® is a peripheral self-expanding stent system consisting of a rapid exchange delivery catheter and a pre-mounted stent made of nitinol. The ...
SOMERSET, NJ (May 12, 2010) – Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced it has received an investigational device exemption (IDE) conditional approval ...
The FDA has approved the Misago Peripheral Stent System from Terumo to treat peripheral artery disease by restoring blood flow to the leg. Upon the FDA's disclosure Terumo almost immediately said it ...
Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced the first U.S. patient implant in the Occlusive/Stenotic Peripheral artery REvascularization StudY (OSPREY), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results